Top compounds associated with response to CTD-3214H19.16


Feature Type Standardized
Nominal ANOVA
mRNA ML050 CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0087 0.8
mRNA BMS-345541 CTRPv2 pan-cancer AAC -0.0087 0.8
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0084 0.8
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.013 0.8
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA B02 CTRPv2 pan-cancer AAC -0.0081 0.8
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.0077 0.8
Download CSV